Result destination
PACS is explicitly referenced as a result destination.
exact submission · checked 2026-09-01Confirm supported products, versions, routing behavior, and display requirements during local evaluation.
FDA-cleared profile
ALPHAPOINT IMAGING SOFTWARE
RADLOGICS, INC.
Authorized purpose: Reviews, analyzes, and interchanges CT chest images to assist medical professionals; it is not for primary interpretation.
Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.
Product overview
Start with the essentials
Authorized purpose: Reviews, analyzes, and interchanges CT chest images to assist medical professionals; it is not for primary interpretation.
Overview status: Source-reviewed overview
- What does this software do? Authorized purpose: Reviews, analyzes, and interchanges CT chest images to assist medical professionals; it is not for primary interpretation.
- Which images or clinical context are in scope? Modality: CT/CTA Anatomy or clinical context: Chest/Lung Input: CT chest images retrieved through PACS/DICOM.
- Who uses it? Intended users: Medical professionals.
- What does the software produce? Output: Segmentation, Hounsfield numerical analysis, substance indications, a Preliminary Findings Report, and user review, verification, and correction tools.
- What is its most important limitation? Key limitation: Not for primary interpretation; users must review, verify, and correct results.
Clinical takeaway
Clinical role: Reviews, analyzes, and interchanges CT chest images to assist medical professionals; it is not for primary interpretation.
Evidence takeaway
Evidence from the reviewed source record: Software verification and validation, DICOM compliance, six DICOM-specific test cases, and independent validation-engineer review; no clinical performance metrics were reported.
Clinical details
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
- Exact purpose
- Reviews, analyzes, and interchanges CT chest images to assist medical professionals; it is not for primary interpretation.
Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.
- Intended users
- Medical professionals.
FDA packet intended-user statement.
- Care setting and population
- Research pending
Confirm the intended care setting, patient population, and service line.
- Workflow role
- Segmentation or contouring
Conservative normalization of explicit wording in an exact-submission source.
- Required input
- CT chest images retrieved through PACS/DICOM.
FDA packet image-input statement.
- Output and human action
- Segmentation, Hounsfield numerical analysis, substance indications, a Preliminary Findings Report, and user review, verification, and correction tools.
FDA packet device-description scope.
- Limitations
- Not for primary interpretation; users must review, verify, and correct results.
Exact FDA limitation.
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
- FDA submission
- K120161
- Modality
- CT/CTA
FDA specifies CT chest; catalog uses CT/CTA as its controlled CT bucket.
- Anatomy
- Chest/Lung
FDA chest scope with lung among the listed substance indications.
- Clearance type
- 510(k)
- Decision date
- 2012-04-13
- FDA status
- FDA-cleared
Implementation
Questions for IT, informatics, and operations
Use these fields to structure a vendor demo, security review, and implementation estimate.
- Integration
- The exact-submission ACR model card explicitly references PACS in the described input, output, or workflow; exact interfaces, versions, and local compatibility require confirmation.
Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.
- Deployment and data flow
- Vendor documentation pending
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
- Security and privacy
- Vendor documentation pending
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
- Training and support
- Vendor documentation pending
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
- Monitoring and change control
- Vendor documentation pending
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Supported acquisition environment
Scanner manufacturers: All
exact submission · checked 2026-09-01Confirm currently supported software versions, protocols, and site-specific acquisition configurations.
ACR exact-submission catalog context
ACR AI Central provides an exact-submission model card for ALPHAPOINT IMAGING SOFTWARE; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-09Evidence
Performance evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
- Evidence summary
- Software verification and validation, DICOM compliance, six DICOM-specific test cases, and independent validation-engineer review; no clinical performance metrics were reported.
Packet testing description; not clinical-performance evidence.
- Reported sensitivity
- Research pending
This field has not been curated yet.
- Reported specificity
- Research pending
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Costs and setup
Budget and ongoing governance
These are common procurement questions; unknown values remain visible until a source supports them.
- Pricing and total cost
- Vendor documentation pending
No public price or quote for the exact K120161 configuration was established in this review.
- Reimbursement and coding
- Not established in reviewed sources
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
- Postmarket safety review
- The exact-identifier FDA recall query returned no native recall record for K120161. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
Buyer worksheet
Open questions to take to the vendor
- Verify care setting and population: Confirm the intended care setting, patient population, and service line.
- Verify deployment and data flow: The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
- Verify security and privacy controls: Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
- Verify training: Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
- Verify pricing and total cost: No public price or quote for the exact K120161 configuration was established in this review.
- Verify reimbursement and coding relevance: No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
- Verify local validation and lifecycle monitoring: Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Research record
What has been checked
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
21Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Sources & history
How this profile was documented
Open the ledger for source dates, scope, and research-record updates.
View source ledger and history
Source ledger
-
FDA K120161: ALPHAPOINT IMAGING SOFTWARE
Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary
-
Artificial Intelligence-Enabled Medical Devices
Scope: regulatoryIdentity, modalityContext
-
AlphaPoint Imaging Software model card (K120161)
Scope: intendedUsers, output, limitations, integration, anatomy, implementationCapabilities
-
PubMed biomedical literature index
Scope: evidenceDiscovery
-
ClinicalTrials.gov study registry
Scope: evidenceDiscovery, studyStatus
-
openFDA Device Recall API
Scope: recallDiscovery, nativeSubmissionMatching
-
openFDA exact recall query for K120161
Scope: postmarketSafety
Research history
-
K120161 FDA decision
Regulatory record
510(k)
-
Source-review record updated
Research record
fda record reviewed
-
Reader overview source-reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Related tools to compare
FDA-cleared K251474
Median LCS (internal name) / eyonis LCS (trade name) (1.0)
Median Technologies
eyonis LCS is a concurrent-reading aid for radiologists that detects, localizes, and characterizes 4-30 mm solid and part-solid pulmonary nodules on low-dose chest CT images for...
- Modality
- CT/CTA
- Anatomy
- Chest/Lung
- Decision
- 2026-02-06
FDA-cleared K251203
AVIEW Lung Nodule CAD
Coreline Soft Co.,Ltd
Adjunctive alert and second-reader information for radiologists interpreting non-contrast chest CT in asymptomatic populations; the cleared nodule range is 3-20 mm.
- Modality
- CT/CTA
- Anatomy
- Chest/Lung
- Decision
- 2025-12-03
FDA-cleared K250766
LungQ 4
Thirona BV
Quantitative support for thoracic CT interpretation and treatment planning, including emphysema burden, airway/lung segmentation, endobronchial valve assessment and estimated...
- Modality
- CT/CTA
- Anatomy
- Chest/Lung
- Decision
- 2025-10-02
FDA-cleared K240554
InferRead Lung CT.AI
Infervision Medical Technology Co., Ltd.
Adjunctive pulmonary nodule detection and measurement, including temporal comparison, in chest CT screening of asymptomatic adults aged at least 55 years.
- Modality
- CT/CTA
- Anatomy
- Chest/Lung
- Decision
- 2025-05-16